“IP Literature Watch” is a periodic newsletter containing an overview of recent publications concerning intellectual property issues around the world.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...